Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business Research Store is run by Sector Publishing Intelligence Ltd. SPi has been selling professional market research reports and company analyses for over 7 years. Our experienced staff team are on hand to help with any research enquiries you may have, and help you find the right report for your needs. We sell reports to businesses of all sizes across the world who need current market data to plan and develop their business strategies. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1305 753769 or Email: office@sectorpublishing.com 2
Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Atreca Inc (Atreca) is a biotechnology company that develops novel therapies based on the human immune response. The company offers therapeutic programs which are focused on cancer immunotherapy s which also includes therapeutics that optimizes the anti-tumor immune responses and infectious diseases. Its proprietary Immune Repertoire Capture (IRC) technology provides unbiased and virtually error-free antibody and T cell receptor (TCR) sequences from the adaptive immune responses. The company s technology is licensed in partnerships with pharmaceutical companies, non-profit foundations, academic institutions and the US Government. It seeks to work in collaboration with other organizations for target discovery, immune profiling, discovery and development of antibody-based therapeutics, vaccines and diagnostics for various therapeutic areas. Atreca is headquartered in Redwood City, California, the US. Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. 3
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH431798D Number of Pages : 21 Report Format : PDF Publisher Information : 4
5
Table Of Contents for Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 12-04-2018] Table of Contents Table of Contents 3List of Tables 4List of Figures 4Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9Atreca Inc, Pharmaceuticals & Healthcare, Deal Details 10Venture Financing 10Atreca Raises USD35 Million in Series B Financing 10Atreca Raises USD56 Million in Series A Financing 11Atreca Raises USD57.26 Million in Venture Financing 12Partnerships 13Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 13Atreca Enters into Agreement with Genome Institute of Singapore 14Atreca Enters into Research Agreement with Janssen Biotech 15Atreca Enters into Agreement with Bill & Melinda Gates Foundation 16Licensing Agreements 17Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 17Atreca Inc - Key Competitors 18Atreca Inc - Key Employees 19Atreca Inc - Locations And Subsidiaries 20Head Office 20Appendix 21Methodology 21About GlobalData 21Contact Us 21Disclaimer 21 6
List Of Tables in Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 12-04-2018] List of Tables Atreca Inc, Pharmaceuticals & Healthcare, Key Facts 2 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Atreca Inc, Deals By Therapy Area, 2012 to YTD 2018 8 Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9 Atreca Raises USD35 Million in Series B Financing 10 Atreca Raises USD56 Million in Series A Financing 11 Atreca Raises USD57.26 Million in Venture Financing 12 Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 13 Atreca Enters into Agreement with Genome Institute of Singapore 14 Atreca Enters into Research Agreement with Janssen Biotech 15 Atreca Enters into Agreement with Bill & Melinda Gates Foundation 16 Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 17 Atreca Inc, Key Competitors 18 Atreca Inc, Key Employees 19 7
List Of Figures, Charts and Diagrams in Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 12-04-2018] List of Figures Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 8
How to Buy... Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 12-04-2018] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at office@sectorpublishing.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1305 753769 We will be delighted to give you our personal attention. 9